Historical salary details - Dr. Ofra Levy-Hacham, Vice President, Clinical and Regulatory Affairs, Sol-Gel Technologies Ltd
Dr. Ofra Levy-Hacham is the Vice President, Clinical and Regulatory Affairs of Sol-Gel Technologies Ltd and his latest salary was 4.0 M. View his historical salary.
Dr. Ofra Levy-Hacham
Vice President, Clinical and Regulatory Affairs
$ 4.0 M
Gross Remuneration
-
Current Company
Sol-Gel Technologies Ltd
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2023 | Sol-Gel Technologies Ltd | - | 4.0 M | 799.3 % |
| 2022 | Sol-Gel Technologies Ltd | Vice President, Clinical and Regulatory Affairs | 447 K | 56.3 % |
| 2021 | Sol-Gel Technologies Ltd | - | 286 K | 1.8 % |
| 2021 | Sol-Gel Technologies Ltd | Vice President, Clinical and Regulatory Affairs | 286 K | 1.8 % |
| 2020 | Sol-Gel Technologies Ltd | - | 281 K | - |
| 2020 | Sol-Gel Technologies Ltd | - | 281 K | - |
| 2020 | Sol-Gel Technologies Ltd | Vice President, Clinical and Regulatory Affairs | 281 K | - |
| 2019 | Sol-Gel Technologies Ltd | Vice President, Clinical and Regulatory Affairs | - | - |
| 2018 | Sol-Gel Technologies Ltd | Vice President Clinical and Regulatory Affairs | - | - |
| 2017 | Sol-Gel Technologies Ltd | Vice President Clinical and Regulatory | - | - |